Accueil › Cancer métastatique › Texas
Essais cliniques pour Cancer métastatique dans Texas
139 études pour Cancer métastatique recherchent des participants dans Texas.
Villes dans Texas
- Houston104 études
- San Antonio44 études
- Dallas42 études
- Austin19 études
- Irving11 études
- The Woodlands9 études
- League City7 études
- Fort Worth7 études
- Tyler5 études
- El Paso5 études
- McAllen5 études
- Abilene5 études
- Sugar Land4 études
- Killeen4 études
- Beaumont3 études
- Brownsville3 études
- Pearland3 études
- Pharr3 études
- Lewisville3 études
Texte officiel de l'étude (anglais)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Hendrick Medical Center, Abilene
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- Lyndon Baines Johnson General Hospital, Houston
- et 2 autres
Recrutement en coursPhase 2
Tous âges · Tous sexes · Mis à jour le 2 oct. 2026 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- New Experimental Therapeutics - NEXT Oncology, Austin
- Texas Oncology, Bedford
- UT Southwest Simmons Cancer Center, Dallas
- et 2 autres
Recrutement en coursPhase 1/2
Âges de 12 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT04585750A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Texas Oncology - West Texas, Abilene
- Texas Oncology - Austin, Austin
- Texas Oncology - San Antonio, San Antonio
- et 1 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT07562152Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- UT MD Anderson Cancer Center, Houston
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT05372614A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- NEXT Austin, Austin
- START Center for Clinical Research, Fort Worth
- University of Texas MD Anderson Cancer Center, Houston
- et 1 autres
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT06270706A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
- Research Site, Houston
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT07205822A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
- University Medical Center & Texas Tech Health Science Center, Lubbock
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT06234605A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- NEXT Oncology, Austin
- UT Southwestern, Dallas
Recrutement en coursPhase 1
Âges de 19 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT06586957A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT07213817Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- University of Texas - MD Anderson Cancer Center, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT05287945Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- SCRI at Mary Crowley, Dallas
- University of Texas Southwestern Medical Center, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- et 1 autres
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT06625775A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 5, Houston
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 30 sept. 2026 · NCT07085091A Study of ASP3082 in Adults With Advanced Solid Tumors
- NEXT Oncology, San Antonio
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 30 sept. 2026 · NCT05382559First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- University of Texas M.D. Anderson Cancer Center, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 29 sept. 2026 · NCT05875168Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Texas Oncology- Baylor Charles A. Sammons Cancer Center, Dallas
Recrutement en coursPhase 2/3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 29 sept. 2026 · NCT06943755Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - West Texas, Amarillo
- Texas Oncology - Gulf Coast, Beaumont
- et 27 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07222800A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- START Dallas Fort Worth, Fort Worth
- MD Anderson, Houston
- NEXT Oncology Houston, Houston
- et 1 autres
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07277413Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor Diagnosis
- M D Anderson Cancer Center, Houston
Recrutement en coursVolontaires sains bienvenus
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT05059678A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas
- Baylor College of Medicine, Houston
Recrutement en coursPhase 1/2
Jusqu'à 25 ans · Tous sexes · Mis à jour le 25 sept. 2026 · NCT04094610Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - Northeast Texas, Allen
- Texas Oncology - West Texas, Amarillo
- et 52 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07222566A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- et 3 autres
Recrutement en coursPhase 2/3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06989437A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- NEXT Oncology, Austin
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
- et 3 autres
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07612176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Dallas
- Research Site, El Paso
- Research Site, Sugar Land
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- University of Texas Southwestern Medical Center, Dallas
- Houston Methodist Cancer Center, Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
Recrutement en coursPhase 2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07007559Intratumoral N17350 in Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 23 sept. 2026 · NCT07339176A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- USO-Texas Oncology-Central/South Texas, Austin
- World Research Link, Baytown
- Parkland Health and Hospital System, Dallas
- et 5 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07218380Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
- Oncology Consultants, P.A., Houston
Recrutement en coursÉtude observationnelle
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07028489A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Hendrick Medical Center, Abilene
- World Research Link, Baytown
- Parkland Health and Hospital System, Dallas
- et 10 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07174336Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- et 1 autres
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Texas Oncology - DFW (Sammons CC), Dallas
- MD Anderson Cancer Center, Houston
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07114601EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- START Dallas Fort Worth, Fort Worth
- University of Texas MD Anderson Cancer Center, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07262619SLV-154 Treatment of Advanced Cancers
- MD Anderson Cancer Center, Houston
- Oncology Consultants, Houston
- Mays Cancer Center; University of Texas Health San Antonio, San Antonio
Recrutement en coursPhase 1
Âges de 12 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06771219A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- USO-Texas Oncology-Central/South Texas, Austin
- UT Southwestern Medical Center, Dallas
- US Oncology, The Woodlands
- et 1 autres
Recrutement en coursPhase 3
Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07213804A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- NEXT Houston, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 21 sept. 2026 · NCT07693751AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- Next Oncology - Dallas, Irving
Recrutement en coursPhase 1
Âges de 18 à 99 · Tous sexes · Mis à jour le 21 sept. 2026 · NCT07403721A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 21 sept. 2026 · NCT07629960Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- M D Anderson Cancer Center, Houston
Recrutement en coursPhase 1
Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT04693468Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Texas Oncology (Balcones) - SCRI, Austin
- MD Anderson Cancer Center, Houston
- START South Texas Accelerated Research Therapeutics, San Antonio
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT05267626Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- et 26 autres
Recrutement en coursPhase 1/2
Âges de 18 ans et plus · Tous sexes · Mis à jour le 17 sept. 2026 · NCT07227415Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.